✦ LIBER ✦

35 A sequence-dependent paclitaxel-etoposide phase II trial in patients with non-small cell lung cancer (NSCLC)

✍ Scribed by Massuti, B.; Felip, E.; González-Larriba, J.L.; Benito, D.; López-Cabrerizo, M.P.; Salamanca, O.; Camps, C.; Puerto-Pica, J.; Rosell, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

169 Phase III trial of paclitaxel (P) an

✍ Boyer, M.J.; Zalcberg, J.; Olver, L.N.; Millward, M.J.; Richardson, G.; McKeage, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 311 KB

A multicenter phase II trial with gemcit

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

A review of etoposide in patients with n

✍ Itri, L.M.; Gralla, R.J. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 398 KB

1070 Phase II trial with docetaxel in pa

✍ Latreille, J.; Laberge, F.; Viallet, J.; Maksymiuk, A.; Shepherd, F.; Gelmon, K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Preoperative treatment with paclitaxel a

✍ De Candis, D; Stani, S.C; Bidoli, P; Potepan, P; Bedini, V.A; Cataldo, I; Michet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase I study of paclitaxel in combina

✍ Ukena, Dieter; Berg, Monika; Leutz, Michaela; Zell, Lothar; Schlimmer, Paul; Syb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 72 KB